Assistant Professor

Renal Replacement Therapy & Dialysis Technology


    Bharathi is Assistant Professor in Renal Replacement Therapy & Dialysis Technology, MCHP, MAHE, Manipal

    She is:

    • Involved in development and preparation of  curriculum
    • Teaching, Clinical demonstrating, supervising the students.
    • Supervises clinical postings & hands-on training for the students         at the dialysis unit
    • Involved in Renal Supportive Care clinics &  family counselling  


Subject Semester / Year
Applied Dialysis - I 1st year/ 1st semester UG
Dialysis Technology I 2nd Year / 3rd semester UG
Dialysis technology III 3rd year/ 5th semester UG
Clinical Skills - V 3rd year/ 5th semester UG
Kidney disease & dialysis therapy 1st Year/1st semester PG
Comprehensive clinical skill – I 1st Year/1st seester PG
Nutrition and Psychosocial aspects in renal failure patients. 2nd Year/3rd semester PG
Research Project-II 2nd Year/3rd semester PG
Vascular access and Kidney transplantation physical counselling 2nd Year/3rd semester PG
Healthy Kidney for Better Living 2nd Year/3rd semester UG, 3rd Year/5th semester UG


Degree Specialisation Institute Year of passing
Inservice PhD Scholar Integrated Renal Supportive Care
M.Sc. Renal Replacement Therapy & Dialysis Technology School of Allied Health Sciences, Manipal 2017
B.Sc. Botany, Zoology, Chemistry (BZC) Kuvempu University 2013
Diploma Renal Replacement Therapy & Dialysis Technology School of Allied Health Sciences, Manipal 2011


Institution / Organisation Designation Role Tenure
Renal Replacement Therapy & Dialysis Technology, MCHP, Manipal Assistant Professor Teaching 2022- till date
Renal Replacement Therapy & Dialysis Technology, MCHP, Manipal Assistant Lecturer Clinical & Teaching 2017 - 2022
Kasturba Hospital, Manipal Dialysis Technician - 1 Clinical 2011 -2017


Area of Interest

Renal replacement therapies, Transplantation, Patient care

Area of Expertise

HD, PD, CRRT, SLED, SLED - F, Hemadsorption, Plasmaphersis, ICU Dialysis & Maintenance of water treatment plant

Area of Research

Renal Supportive Care

End of Life Care in End Stage Kidney Disease

30/05/2021 Pallative care in ESKD patients Prabhu RA Salins N Bharathi Abraham G.

There is a rise in burden of end‑stage renal disease globally and in India. The symptom burden, prognosis, and mortality in chronic kidney disease closely mimics that of cancer. However, the palliative and end of life care needs of these patients are seldom addressed. A consensus opinion statement was developed outlining the provision of end of life care in end‑stage kidney disease. Recognition of medical futility, consensus on medical futility, and cessation of potentially inappropriate therapies and medications are the initial steps in providing end of life care. Conducting a family meeting, communicating prognosis, discussing various treatment modalities, negotiating goals of care, shared decision‑making, and discussion and documentation of life sustaining treatment are essential aspects of end of life care provision. The provision of end of life care entails assessment and the management of end‑stage kidney disease symptoms and the care extends beyond the death of the patient to their families in the bereavement period.

Intradialytic hypertension prevalence and predictive factors: A single centre study

05/06/2021 Hemodialysis Prabhu RA Naik B Bhojaraja MV Rao IR Shenoy SV Nagaraju SP Rangaswamy D.

Introduction: Intradialytic hypertension (IDH) is associated with significant vascular and cardiac adverse outcomes. Objectives: This study was performed to know the prevalence and factors predicting IDH. Patients and Methods: A single-center cross-sectional observational study at a tertiary care hospital. After ethics committee approval and informed consent, all patients over 18 years on twice weekly hemodialysis were included, those on peritoneal dialysis and acute kidney injury excluded. Primary outcome was prevalence of IDH based on three definitions and secondary outcome was predictive factors. IDH was defined as ≥10 mm Hg surge in systolic blood pressure (SBP) between pre-and post-dialysis in 4 of 6 successive sessions or >15 mm Hg rise in mean arterial pressure (MAP) between start and end of dialysis or symptomatic rise in blood pressure requiring intervention. SBP and MAP were measured on standardized monitors before, hourly and 30 minutes post dialysis. Results: Of 136 patients, prevalence of intra-dialytic hypertension was 78/136 (57%), 33/136 (24%), 15/136 (11%) based on systolic rise, rise in MAP and symptomatic rise in BP respectively. Among those with systolic rise, diabetes mellitus (P = 0.03), undernourishment (P = 0.03), inter-dialytic weight gain >3 kg (P < 0.001) and dialysis vintage > 3 years (P < 0.001) were significantly associated with IDH. Conclusion: IDH prevalence varied from 11 to 57% with different definitions. Diabetes mellitus, under nutrition, inter-dialytic weight gain >3 kg and dialysis vintage >3 years predicted IDH.

Kannada Translation and Validation of the ESAS-r Renal for Symptom Burden Survey in Patients with End-Stage Kidney Disease

30/05/2023 Pallative care in ESKD patients Bharathi Naik Shankar Prasad Nagaraju Vasudeva Guddattu Naveen Salins Ravindra Prabhu Anuja Damani Prathvi Naik Krithika S. Rao Indu Ramachandra Rao Pankaj Singhai

Objectives: End-stage kidney disease (ESKD) is a life-limiting illness that leads to significant health-related suffering for the patients and their caregivers. Moreover, disease-directed options such as dialysis and renal transplant might not be universally accessible. Inadequate assessment and management of symptoms often lead to diminished quality of life. For evaluating symptoms and their associated distress, various tools have been identified. However, these are not available for the native Kannada-speaking population for assessing ESKD symptom burden. In this study, we determined the reliability and validity of the Edmonton Symptom Assessment System Revised Renal (ESAS-r: Renal) in Kannada-speaking ESKD patients. Materials and Methods: ESAS-r: Renal English version was translated into Kannada using the forward and backward method. The translated version was endorsed by Nephrology, Palliative care, Dialysis technology and Nursing experts. As a pilot study, 12 ESKD patients evaluated the content of the questionnaires for appropriateness and relevance. The ESAS-r: Renal Kannada version was validated by administering this tool to 45 patients twice a fortnight. Result: The translated ESAS-r: Renal Kannada version questionnaire had an acceptable face and content validity. Experts’ opinion was assessed by content validity ratio (CVR), and the value of CVR of ESAS-r: Renal Kannada version was-‘1’-. Internal consistency of the tool was assessed among Kannada-speaking ESKD patients; its Cronbach’s α was 0.785, and test-retest validity was 0.896. Conclusion: The validated Kannada version of ESAS-r: Renal was reliable and valid for assessing symptom burden in ESKD patients.